...
首页> 外文期刊>Molecular pharmacology. >Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-(2-(4-(2-chlorobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine (KMUP-1) and 7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1, 3-dimeth
【24h】

Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-(2-(4-(2-chlorobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine (KMUP-1) and 7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1, 3-dimeth

机译:黄嘌呤基的7-(2-(4-(2-(4-氯苯)哌嗪基)乙基)-1,3-二甲基黄嘌呤(KMUP-1)和7-(2-(4-(4-(4-硝基苯)哌嗪基)乙基)-1,3-二甲基

获取原文
获取原文并翻译 | 示例
           

摘要

In the study of anti-proinflammation by 7-[2-[4-(2-chlorobenzene)piperazinyl] ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-3), exposure of rat tracheal smooth muscle cells (TSMCs) to tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, increased the expression of inducible nitric-oxide synthase (iNOS) and NO production and decreased the expression of soluble guanylate cyclase alpha1 (sGCalpha1), soluble guanylate cyclase beta1 (sGCbeta1), protein kinase G (PKG), and the release of cGMP in TSMCs. The cell-permeable cGMP analog 8-Br-cGMP, xanthine-based KMUP-1 and KMUP-3, and the phosphodiesterase 5 inhibitor zaprinast all inhibited TNF-alpha-induced increases of iNOS expression and NO levels and reversed TNF-alpha-induced decreases of sGCalpha1, sGCbeta1, and PKG expression. These results imply that cGMP enhancers could have anti-proinflammatory potential in TSMCs. TNF-alpha also increased protein kinase A (PKA) expressionand cAMP levels, cyclooxygenase-2 (COX-2) expression, and activated productions of prostaglandin (PG) E2 and 6-keto-PGF1alpha (stable PGI2 metabolite). Dexamethasone and N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methane sulfonamide (NS-398; a selective COX-2 inhibitor) attenuated TNF-alpha-induced expression of COX-2 and activated productions PGE2 and PGI2. However, KMUP-1 and KMUP-3 did not affect COX-2 activities and did not further enhance cAMP levels in the presence of TNF-alpha. It is suggested that TNF-alpha-induced increases of PKA expression and cAMP levels are mediated by releasing PGE2 and PGI2, the activation products of COX-2. In conclusion, xanthine-based KMUP-1 and KMUP-3 inhibit TNF-alpha-induced expression of iNOS in TSMCs, involving the sGC/cGMP/PKG expression pathway but without the involvement of COX-2.
机译:在7- [2- [4-(2-氯苯)哌嗪基]乙基] -1,3-二甲基黄嘌呤(KMUP-1)和7- [2- [4- [4-(4-硝基苯)]抗炎药的研究中哌嗪基]乙基] -1,3-二甲基黄嘌呤(KMUP-3),大鼠气管平滑肌细胞(TSMC)暴露于促炎性细胞因子肿瘤坏死因子-α(TNF-α),可诱导一氧化氮的表达增加合酶(iNOS)和一氧化氮的产生并降低了可溶性鸟苷酸环化酶alpha1(sGCalpha1),可溶性鸟苷酸环化酶beta1(sGCbeta1),蛋白激酶G(PKG)的表达以及cGMP在台积电中的释放。细胞可渗透的cGMP类似物8-Br-cGMP,基于黄嘌呤的KMUP-1和KMUP-3以及磷酸二酯酶5抑制剂扎普林斯特均抑制TNF-alpha诱导的iNOS表达和NO水平升高,并逆转TNF-alpha诱导的sGCalpha1,sGCbeta1和PKG表达的减少。这些结果表明,cGMP增强剂可能在台积电中具有抗促炎作用。 TNF-α还增加了蛋白激酶A(PKA)的表达和cAMP水平,环氧合酶2(COX-2)的表达,并激活了前列腺素(PG)E2和6-酮基-PGF1alpha(稳定的PGI2代谢产物)的产生。地塞米松和N- [2-(环己氧基)-4-硝基苯基]-甲烷磺酰胺(NS-398;选择性COX-2抑制剂)减弱了TNF-α诱导的COX-2表达并激活了产物PGE2和PGI2。但是,在存在TNF-α的情况下,KMUP-1和KMUP-3不会影响COX-2的活性,也不会进一步提高cAMP的水平。提示TNF-α诱导的PKA表达和cAMP水平的增加是通过释放COX-2的活化产物PGE2和PGI2介导的。总之,基于黄嘌呤的KMUP-1和KMUP-3抑制TNF-α诱导的TSMC中iNOS的表达,涉及sGC / cGMP / PKG表达途径,但不涉及COX-2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号